Forrest General Hospital Selects Advanced Transfusion Management System From Global Med Technologies(R), Inc.

DENVER, April 20 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R), a division of Global Med Technologies(R), Inc. (BULLETIN BOARD: GLOB) ("Global Med" or the "Company"), announced the signing of an agreement for SafeTrace Tx(R)*, its advanced transfusion management system, with Forrest General Hospital in Hattiesburg, Mississippi. Terms of the agreement were not disclosed.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO )

"We selected SafeTrace Tx for its ability to adapt to any size operation -- from a small single site facility to a large multi-facility organization, thus providing options for growth and change," said Sandi Thames, Chief Technologist of Forrest General Hospital's Clinical Laboratory. Ms. Thames added, "SafeTrace Tx is operational in many very active and prestigious institutions -- it is a tried and true product."

Wm. Scott Dustin, Wyndgate's Vice President of Sales and Marketing, said, "We are pleased to have been selected to provide our products and services to enhance the transfusion service management of a well-established and prominent facility such as Forrest General Hospital." Mr. Dustin continued by saying, "The delivery of accessible, quality healthcare is important to both Forrest General Hospital and Wyndgate Technologies."

About Forrest General Hospital

Forrest General Hospital system has delivered health care services to Hattiesburg since 1952, and currently provides assistance to a 16-county area of South Mississippi. The regional medical center has grown remarkably from 90 beds to a 537-bed facility.

Forrest General Hospital consists of a 429-bed acute care facility; Pine Grove, an 88-bed chemical dependency and psychiatric unit; Rehabilitation Services, a 20-bed rehabilitation unit; Lowery A. Woodall Outpatient Surgery Facility; and Forrest General Home Care and Hospice.

Today, Forrest General enjoys a reputation for quality health care services rivaling any health care system in the southeastern United States. It now is one of the most advanced and well-equipped medical centers in the region.

About Global Med Technologies, Inc.

Global Med Technologies, Inc. is an international e-Health, medical information technology company, providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Current clients of Wyndgate's products and services manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. Wyndgate's products are also being implemented in Canada, the Caribbean and sub-Sahara Africa. Together, the SafeTrace Tx advanced transfusion management system and the SafeTrace(R) donor management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and

services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/.

This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.

* Patent Pending

Photo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGOAP Archive: http://photoarchive.ap.org/PRN Photo Desk, photodesk@prnewswire.comGlobal Med Technologies, Inc.

CONTACT: Michael I. Ruxin, M.D., Global Med Technologies, Inc.,+1-303-238-2000; or John Nesbett or Jordan Silverstein, both of The InvestorRelations Group, +1-212-825-3210, for Global Med Technologies, Inc.

Back to news